Haematology

Prof. Dr. Anıl Tombak

Doctor and researcher Medical Park Mersin Mersin

Leukemia, Myeloid, AcuteHemoglobinuria, ParoxysmalMyelodysplastic SyndromesHodgkin DiseaseAnemia, Sickle CellLeukemia, Lymphocytic, Chronic, B-CellPolycythemia VeraFeverLeukemia, Hairy CellMultiple MyelomaPurpura, Thrombocytopenic, IdiopathicNeoplasmsPeptic Ulcer

Open institution page

Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source

Leukemia, Myeloid, Acute 4 publications

Source: OpenAlex / PubMed MeSHView publications
Hemoglobinuria, Paroxysmal 4 publications
Myelodysplastic Syndromes 3 publications
Hodgkin Disease 2 publications
Anemia, Sickle Cell 2 publications
Leukemia, Lymphocytic, Chronic, B-Cell 2 publications
Polycythemia Vera 2 publications
Fever 2 publications
Leukemia, Hairy Cell 2 publications
Multiple Myeloma 2 publications
Purpura, Thrombocytopenic, Idiopathic 2 publications
Neoplasms 2 publications
Peptic Ulcer 2 publications

Education and experience

From source

Experience

Experience04.2016 Mersin Üniversitesi Sağlık Bilimleri Doçentmedicalpark.com.tr
Experience06.2013-04.04.2016 Mersin Üniversitesi Sağlık Bilimleri Yardımcı Doçentmedicalpark.com.tr
Experience04.2016-25.04.2019 Mersin Üniversitesi Tıp Fakültesi Mezuniyet Sonrası Eğitim Koordinasyon Kurul Üyesimedicalpark.com.tr
Experience04.2013-24.04.2016 Mersin Üniversitesi Tıp Fakültesi Koordinasyon Kurul Üyesimedicalpark.com.tr

Education

Education2000 Çukurova Üniversitesi Tıp Fakültesimedicalpark.com.tr
Education2008 Mersin Üniversitesi Tıp Fakültesi İç Hastalıkları Uzmanlıkmedicalpark.com.tr
Education2013 Mersin Üniversitesi Tıp Fakültesi Hematoloji Uzmanlıkmedicalpark.com.tr

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

SpecialtyHaematologymedicalpark.com.trFrom source
Department name at the sourceHematoloji Polikliniğimedicalpark.com.trFrom source
InstitutionMedical Park Mersinmedicalpark.com.trFrom source
Area of workLeukemia, Myeloid, AcuteExtracted from 4 publications · Model version —From source
Publications113 publicationsOpenAlex, ORCIDFrom source
ORCID0000-0002-7195-1845ORCIDFrom source
Last synchronised4 November 2026 20:26https://www.medicalpark.com.tr/hekimler/anil-tombakmedicalpark.com.tr

Scientific work

Publications on Leukemia, Myeloid, Acute

113 publications

Real-world effectiveness and safety of fixed-duration frontline venetoclax–obinutuzumab for chronic lymphocytic leukemia: A nationwide multicenter retrospective cohort study

Leukemia Research, 2026

DOI 10.1016/j.leukres.2026.108342 PMID 42933070 Source: OpenAlex
Real-World Outcomes of Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia

Hemato, 2026

DOI 10.3390/hemato7020016 Open-access full textSource: ORCID
Circadian Deregulation in Multiple Myeloma: BMAL1 / CLOCK Expression Patterns and Diagnostic Performance

International Journal of Laboratory Hematology, 2026

DOI 10.1111/ijlh.70154 PMID 42167790 1 citation (OpenAlex) Open-access full textSource: OpenAlex
FACIT-fatigue score and treatment quality assessment for paroxysmal nocturnal hemoglobinuria patients treated with Eculizumab in Türkiye

PLoS ONE, 2026

DOI 10.1371/journal.pone.0355720 PMID 42726724 Open-access full textSource: OpenAlex
Extranodal Nasal-Type NK/T-Cell Lymphoma Treatment: Analysis from a Multicenter Study

Nigerian Journal of Clinical Practice, 2025

DOI 10.4103/njcp.njcp_499_24 PMID 40462333 Open-access full textSource: OpenAlex
Diagnostic and Prognostic Significance of miR-155, miR-181, miR-221, miR-222, and miR-223 Expression in Myelodysplastic Syndromes and Acute Myeloid Leukemia

Diagnostics, 2025

DOI 10.3390/diagnostics16010013 PMID 41515508 1 citation (Europe PMC) Open-access full textSource: ORCID
Disrupted miRNA Biogenesis Machinery Reveals Common Molecular Pathways and Diagnostic Potential in MDS and AML

Biomedicines, 2025

DOI 10.3390/biomedicines13123082 PMID 41463093 Open-access full textSource: ORCID
Practical Guidance on the Clinical Management of Belantamab Mafodotin for Patients With Relapsed/Refractory Multiple Myeloma: Recommendations From the Middle East and North Africa Expert Panel

Clinical Lymphoma Myeloma and Leukemia, 2025

DOI 10.1016/j.clml.2025.05.019 PMID 40579284 3 citations (Europe PMC) Open-access full textSource: ORCID
Ten-year journey with myelofibrosis: real-world data and clinical outcomes from a tertiary care center

Journal of Current Hematology & Oncology Research, 2025

DOI 10.51271/jchor-0063 Open-access full textSource: ORCID
Comparison of classical and flowcytometric osmotic fragility and flowcytometric eosin-5-maleimide binding tests in diagnosis of hereditary spherocytosis

Turkish Journal of Biochemistry, 2025

DOI 10.1515/tjb-2024-0197 Open-access full textSource: ORCID

View all 113 publications

Other doctors working on these diseases

Memberships and more

International congresses attended (1)

İyi Klinik Uygulamalar Eğitimi, Sağlık Bakanlığı

Source: medicalpark.com.tr

Ask Doctoria AI

Coming soon

In preparation for doctors, institutions and research teams. Examples of questions you will be able to ask:

Find the doctors with the most publications in Haematology Find the researchers scientifically closest to this profile Find researchers for a multicentre study

Let’s improve this profile together

Every change is stored with its source, contributor and date.

Suggest a correction Add a publication Correct the institution Add a specialty Merge a duplicate record Claim profile

Last change: 54 yayın ORCID kimliğiyle eklendi Source: https://orcid.org/0000-0002-7195-1845
Contributor: Doctoria bot
Date: 6 November 2026 17:05